Pharmaceutical Policy

Publications authored by CHSPR faculty and staff from 2009 to the present are listed here. Older peer-reviewed publications are usually available from individual journals and can be searched for using PubMed. Older reports published by CHSPR (from 1973) are available from the UBC Library cIRcle database. If you cannot find a specific publication, please contact us.


Wong ST, Morkem R, Leis J, Levinson W, Patey A, Durance A, Barber D. Potentially inappropriate antibiotic prescribing for respiratory tract infections in Canadian primary care: Results from the Canadian Primary Care Sentinel Surveillance Network. Kingston, ON: Canadian Primary Care Sentinel Surveillance Network; April 2022. Read more

McClean AR, Law MR, Harrison M, Bansback N, Gomes T, Tadrous M. Uptake of biosimilar drugs in Canada: analysis of provincial policies and usage data. CMAJ. 2022 Apr 19;194(15):E556-E560. doi: 10.1503/cmaj.211478. Read more

Hofmeister M, Sivakumar A, Clement F, Hayes KN, Law M, Guertin JR, Neville HL, Tadrous M. Trends in Canadian prescription drug purchasing: 2001-2020. J Pharm Policy Pract. 2022 Mar 17;15(1):20. doi: 10.1186/s40545-022-00420-4. Read more

Alves JC, Law MR, Luz TCB. Prevalence and Factors Associated With Out-of-Pocket Pharmaceutical Expenditure Among Primary Healthcare Patients: Evidence From the Prover Project. Value Health Reg Issues. 2022 Mar 17;30:83-90. doi: 10.1016/j.vhri.2022.01.006. Online ahead of print. Read more

Garrison SR, Kolber MR, Allan GM, Bakal J, Green L, Singer A, Trueman DR, McAlister FA, Padwal RS, Hill MD, Manns B, McGrail K, O'Neill B, Greiver M, Froentjes LS, Manca DP, Mangin D, Wong ST, MacLean C, Kirkwood JE, McCracken R, McCormack JP, Norris C, Korownyk T. Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial. BMJ Open. 2022 Feb 24;12(2):e059711. doi: 10.1136/bmjopen-2021-059711. Read more

Morrow RL, Mintzes B, Gray G, Law MR, Garrison S, Dormuth CR. Industry Sponsor Influence in Clinical Trial Reporting in Canada: A Qualitative Interview Study. Clin Ther. 2021 Dec 23:S0149-2918(21)00493-8. Online ahead of print. Read more

Schummers L, Darling EK, Dunn S, McGrail K, Gayowsky A, Law MR, Laba TL, Kaczorowski J, Norman WV. Abortion Safety and Use with Normally Prescribed Mifepristone in Canada. N Engl J Med. 2021 Dec 8. Online ahead of print. Read more

Zeitouny S, Suda KJ, Mitsantisuk K, Law MR, Tadrous M. Mapping global trends in vaccine sales before and during the first wave of the COVID-19 pandemic: a cross-sectional time-series analysis. BMJ Glob Health. 2021 Dec;6(12):e006874. Read more

Tadrous M, Shakeri A, Hayes KN, Neville HL, Houlihan J, Clement F, Guertin JR, Law MR, Gomes T. Canadian Trends and Projections in Prescription Drug Purchases: 2001–2023. Canadian Journal of Health Technologies. 2021;1(11). Read more

Persaud N, Bedard M, Boozary A, Glazier RH, Gomes T, Hwang SW, Juni P, Law MR, Mamdani M, Manns B, Martin D, Morgan SG, Oh P, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Laupacis A; Carefully seLected and Easily Accessible at No Charge Medications (CLEAN Meds) study team. Adherence at 2 years with distribution of essential medicines at no charge: The CLEAN Meds randomized clinical trial. PLoS Med. 2021 May 21;18(5):e1003590. Read more

Chew C, Aguiar M, Bansback N, Law MR, Harrison M. Patient perspectives on the British Columbia Biosimilars Initiative: a qualitative descriptive study. Rheumatol Int. 2021 May 7:1-12. Read more

Ho H, Janjua NZ, McGrail KM, Harrison M; BC Hepatitis Testers Cohort Team, Law MR. The impact of public coverage of newer hepatitis C medications on utilization, adherence, and costs in British Columbia. PLoS One. 2021 Mar 1;16(3):e0247843. Read more

Holbrook AM, Wang M, Lee M, Chen Z, Garcia M, Nguyen L, Ford A, Manji S, Law MR. Cost-related medication nonadherence in Canada: a systematic review of prevalence, predictors, and clinical impact. Syst Rev. 2021 Jan 6;10(1):11. Read more

Daw JR, Law MR. Compared With Other Countries, Women In The US Are More Likely Than Men To Forgo Medicines Because Of Cost. Health Aff (Millwood). 2020 Aug;39(8):1334-1342. Read more

Laba TL, Cheng L, Worthington HC, McGrail KM, Chan FKI, Mamdani M, Law MR. What happens to drug use and expenditure when cost sharing is completely removed? Evidence from a Canadian provincial public drug plan. Health Policy. 2020 May 23:S0168-8510(18)30587-6. Online ahead of print. Read more

Kitchen SA, McGrail K, Wickham ME, Law MR, Hohl CM. Emergency department-based medication review on outpatient health services utilization: interrupted time series. BMC Health Serv Res. 2020 Mar 26;20(1):254. Read more

Laba TL, Cheng L, Kolhatkar A, Law MR. Cost-related nonadherence to medicines in people with multiple chronic conditions. Research in Social and Administrative Pharmacy;16(3):415-421.Read more

Law MR, Chan FKI, Harrison M, Worthington HC. Impact of brand drug discount cards on private insurer, government and patient expenditures. CMAJ. 2019 Nov 11;191(45):E1237-E1241. Read more

Bolatova T, Law MR. Income-related disparities in private prescription drug coverage in Canada. CMAJ Open. 2019 Oct 11;7(4):E618-E623. Read more

Persaud N, Bedard M, Boozary AS, Glazier RH, Gomes T, Hwang SW, Jüni P, Law MR, Mamdani MM, Manns BJ, Martin D, Morgan SG, Oh PI, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Laupacis A; Carefully Selected and Easily Accessible at No Charge Medicines (CLEAN Meds) Study Team. Effect on Treatment Adherence of Distributing Essential Medicines at No Charge: The CLEAN Meds Randomized Clinical Trial. JAMA Intern Med. 2019 Oct 7. [Epub ahead of print] Read more